Is Glibenclamide the New Cool in Cardiopulmonary Resuscitation?


REFERENCES 1. Newton’s laws of motion. Available at: Newton%27s_laws_of_motion. Accessed October 5, 2015 2. Morelli A, Donati A, Ertmer C, et al: Microvascular effects of heart rate control with esmolol in patients with septic shock: A pilot study. Crit Care Med 2013; 41:2162–2168 3. Lira A, Pinsky MR: Should β-blockers be used in septic shock? Crit Care 2014; 18:304 4. Morelli A, Ertmer C, Westphal M, et al: Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA 2013; 310:1683–1691 5. Schmittinger CA, Wurzinger B, Deutinger M, et al: How to protect the heart in septic shock: A hypothesis on the pathophysiology and treatment of septic heart failure. Med Hypotheses 2010; 74:460–465 6. Kimmoun A, Louis H, Al Kattani N, et al: β1-Adrenergic Inhibition Improves Cardiac and Vascular Function in Experimental Septic Shock. Crit Care Med 2015; 43:e332–e340 7. Dubin A, Pozo MO, Casabella CA, et al: Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: A prospective study. Crit Care 2009; 13:R92 8. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580–637

DOI: 10.1097/CCM.0000000000001112

Cite this paper

@article{Simard2015IsGT, title={Is Glibenclamide the New Cool in Cardiopulmonary Resuscitation?}, author={J. Marc Simard and Kevin N Sheth}, journal={Critical care medicine}, year={2015}, volume={43 9}, pages={2040-1} }